MARINUS PHARMACEUTICALS, INC. Shareholders' Equity
MARINUS PHARMACEUTICALS, INC. had Shareholders' Equity of -$66.74 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-11-12
- 2024-09-30: Stockholders' Equity Attributable to Parent -$66.74M.
- 2024-06-30: Stockholders' Equity Attributable to Parent -$47.34M.
- 2024-03-31: Stockholders' Equity Attributable to Parent -$16.43M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $16.77M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2024-09-30 | -$66.74M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$47.34M 10-Q · filed 2024-11-12 | |
| 2024-03-31 | -$16.43M 10-Q · filed 2024-11-12 | |
| 2023-12-31 | $16.77M 10-Q · filed 2024-11-12 | |
| 2023-09-30 | $54.54M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $57.34M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $85.08M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $116.00M 10-Q · filed 2024-11-12 | |
| 2022-09-30 | $82.00M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $4.80M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $40.41M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $53.49M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $78.49M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $95.06M 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $115.33M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $137.20M 10-K · filed 2023-03-09 | |
| 2020-09-30 | $87.42M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $101.14M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $43.11M 10-Q · filed 2021-11-09 | $43.11M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $59.57M 10-K · filed 2022-03-24 | |
| 2019-09-30 | $34.07M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $46.59M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $57.74M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $68.33M 10-K · filed 2021-03-09 | |
| 2018-09-30 | $35.12M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $45.02M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $53.13M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $58.01M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $62.10M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $16.29M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $19.25M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $21.48M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $26.69M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $32.33M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $40.57M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $46.92M 10-K · filed 2019-03-12 | |
| 2015-09-30 | $25.66M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $29.88M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $34.73M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $41.15M 10-K · filed 2018-03-07 | |
| 2014-09-30 | $44.23M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$65.86M 10-Q · filed 2014-10-10 | |
| 2013-12-31 | -$60.38M 10-K · filed 2017-03-13 | -$60.38M 10-Q · filed 2014-10-10 |
| 2012-12-31 | -$55.37M 10-K · filed 2015-03-12 |